This page shows the latest eye conditions news and features for those working in and with pharma, biotech and healthcare.
the treatment of cancer, heart conditions and epilepsy. ... of. The 17 new drug shortages identified included cancer drugs, treatments for Parkinson’s, mental health drugs and some eye conditions.
Eye conditions have emerged as one of the leading areas for gene therapy - thanks to factors such as the eye's easy accessibility, it being a highly compartmentalised and immune-privileged ... organ, and decades of research into the genetic basis of
Dry eye disease causes discomfort, stinging and blurry vision, and can significantly affect quality of life in some patients, impacting activities such as reading and using computers. ... It is one of the most common conditions seen by ophthalmologists
It means that we can now offer patients treatment for retinal eye conditions in Coventry as well as Rugby, improving access for patients across our area.”. ... the UK - among other eye conditions.
Clare Bailey, consultant ophthalmologist at Bristol Eye Hospital, explained the benefits of a local service for patients with eye conditions. ... Novartis' interests in the area lie in Lucentis (ranibizumab), which is recommended by the National
The cost will be exacerbated by late diagnosis and the development of complications, such as eye conditions and limb amputation, said the IDF, which issued a call for G20 governments to
More from news
Approximately 1 fully matching, plus 17 partially matching documents found.
was among the estimated one million children in the UK with undiagnosed eye sight issues. ... appointments. In the UK, 53% of children have never had an eye check and there are an estimated one million with undiagnosed eye conditions.
Visudyne treats abnormal blood vessels in the eye associated with conditions such as wet macular degeneration using light activation as photodynamic therapy. ... QLT / Valeant Pharmaceuticals. Product acquisition. Visudyne (verteporfin) for eye
Our combined product portfolios span a broad range of eye conditions, allowing us to better meet our patients' changing needs. ... R&D focus is on discovering new treatments for conditions including age-related macular degeneration (AMD), eye allergies,
More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.
McDermott was most recently VP, business development at Botox developers Allergan, and during his time at the company he completed several transaction and partnership agreements involving such products as eye inflammation ... Kala will benefit from
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
of diseases such as pneumonia, breast and skin cancers, eye diseases, and heart conditions.’[20].
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...